Chelidocystatin, a novel phyocystatin from Chelidonium majus

被引:22
|
作者
Rogelj, B
Popovic, T
Ritonja, A
Strukelj, B
Brzin, J
机构
[1] Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana 1000, Slovenia
[2] Fac Pharm, Ljubljana 1000, Slovenia
关键词
Chelidonium majus; papaveraceae; greater celandine; herbal medicine; cysteine proteinase inhibitor; phytocystatin;
D O I
10.1016/S0031-9422(98)00281-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Greater celandine (Chelidonium majus L.) has traditional uses in European and Chinese herbal medicine. In the plant sap significant inhibitory activity against papain was-observed. A cysteine proteinase inhibitor, named chelidocystatin, was isolated from the plant using papain Sepharose affinity chromatography followed by gel filtration and ion-exchange chromatography. Chelidocystatin showed a M-r of 10 000 on SDS-PAGE with the pi of 9.3, and was a strong inhibitor of cathepsin L (K-i = 5.6 x 10(-11) M), papain (K-i = 1.1 x 10(-10) M) and cathepsin H (K-i = 7.5 x 10(-9) M). The complete amino acid sequence of the protein was obtained with N-terminal sequencing and sequencing of the peptides after digestion of the protein. Moreover, a major part of the sequence was verified by molecular cloning. The conserved glycine residue at the N-terminal region and the QVVAG; motif, which are both believed to be involved in the inhibitory activity, indicate that it is a member of the cystatin superfamily. The amino acid sequence of chelidocystatin shows a high degree of homology with cysteine proteinase inhibitors belonging to the phytocystatin group, especially with the recently described carrot and sunflower phytocystatins with which it shares 57% and 54% homology, respectively. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1645 / 1649
页数:5
相关论文
共 50 条
  • [31] Liver diseases in pets and the homeopathic remedy Chelidonium majus
    Kirkilessi, Georgia
    Loukaki, Katerina
    ZEITSCHRIFT FUER GANZHEITLICHE TIERMEDIZIN, 2007, 21 (03): : 122 - 124
  • [32] GAMMA-IRRADIATION DAMAGE TO LATEX VACUOLE MEMBRANES OF CHELIDONIUM-MAJUS
    SATO, M
    WATANABE, M
    HIRAOKA, A
    PHYTOCHEMISTRY, 1992, 31 (08) : 2585 - 2590
  • [33] HYDROXYCINNAMIC ACID-DERIVATIVES, CAFFEOYLMALIC AND NEW CAFFEOYLALDONIC ACID-ESTERS, FROM CHELIDONIUM-MAJUS
    HAHN, R
    NAHRSTEDT, A
    PLANTA MEDICA, 1993, 59 (01) : 71 - 75
  • [34] Alkaloids from Chelidonium majus and their inhibitory effects on LPS-induced NO production in RAW264.7 cells
    Park, Ji Eun
    Cuong, To Dao
    Tran Manh Hung
    Lee, IkSoo
    Na, MinKyun
    Kim, Jin Cheol
    Ryoo, SungWoo
    Lee, Jeong Hyung
    Choi, Jae Sue
    Woo, Mi Hee
    Min, Byung Sun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 6960 - 6963
  • [35] Chasmothecia of Erysiphe macleayae on Chelidonium majus confirm species identification
    Jiang, Wentao
    Liu, Shuyan
    An, Baoning
    Wang, Lilan
    Li, Yu
    Takamatsu, Susumu
    Braun, Uwe
    MYCOSCIENCE, 2015, 56 (02) : 132 - 135
  • [36] Data mining as a predictive model for Chelidonium majus extracts production
    Borghini, Alice
    Pietra, Danieie
    di Trapani, Claudia
    Madau, Pierluigi
    Lubinu, Giuseppe
    Bianucci, Anna Maria
    INDUSTRIAL CROPS AND PRODUCTS, 2015, 64 : 25 - 32
  • [37] EXTRACTION AND BIOSSAY-DIRECTED FRACTIONATION OF THE CYTOTOXIC METABOLITES FROM CHELIDONIUM-MAJUS
    DEGIULIO, A
    DEROSA, S
    DIVINCENZO, G
    STRAZZULLO, G
    PHYTOCHEMICAL ANALYSIS, 1992, 3 (03) : 122 - 124
  • [38] Occurrence of the sexual morph of Erysiphe macleayae on Chelidonium majus in Romania
    Chinan, Vasilica-Claudiu
    ACTA BOTANICA CROATICA, 2018, 77 (02) : 189 - 192
  • [39] Proteomic analysis of Chelidonium majus milky sap using two-dimensional gel electrophoresis and tandem mass spectrometry
    Nawrot, Robert
    Kalinowski, Andrzej
    Gozdzicka-Jozefiak, Anna
    PHYTOCHEMISTRY, 2007, 68 (12) : 1612 - 1622
  • [40] Effect of Chelidonium majus L on experimental hepatic tissue injury
    Mitra, S
    Sur, RK
    Roy, A
    Mukherjee, AS
    PHYTOTHERAPY RESEARCH, 1996, 10 (04) : 354 - 356